Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers diagnostic testing solutions for the immune system: COVID, Cancer & Alzheimer’s.
Lab Solutions: Our focus on automation has created a commercial infrastructure able to deploy integrated solutions for labs looking to scale services for their core clients.
R&D Pipeline: Evidence suggests that blood-based tests are the future of cancer screening. Our TBIA platform represents a cost-effective, scalable, and patient-friendly screening practice for cancer detection. Videssa® Breast: Cancer Blood Test | LymPro™: Alzheimer's Blood Test | TolloTest™: 3CL Protease Test | TBIA: AI Cancer Platform
Protease Inhibitors: Todos has acquired exclusive distribution rights to the immune boosting, dietary supplement Tollovid™ and is developing Tollovir™, a highly potent 3CL protease inhibitor as a COVID-19 antiviral.
For more information, please visit www.todosmedical.com/.
Shared 2 years ago
180 views
Shared 2 years ago
219 views
Shared 2 years ago
108 views
Shared 2 years ago
135 views
Shared 2 years ago
146 views
Shared 2 years ago
1.5K views
Shared 2 years ago
152 views
Shared 2 years ago
208 views
Shared 2 years ago
119 views
Shared 2 years ago
199 views
Shared 2 years ago
396 views
Sequire Spotlight interviewed Todos Medical Ltd TOMDF President and CEO at the LD Micro Invitational
Shared 3 years ago
195 views
Shared 3 years ago
106 views
Shared 3 years ago
234 views
Shared 3 years ago
81 views
Shared 3 years ago
92 views
Shared 3 years ago
911 views
Shared 3 years ago
202 views
Shared 3 years ago
302 views
Shared 3 years ago
346 views
Shared 3 years ago
205 views
Shared 3 years ago
55K views
Shared 3 years ago
166 views
Shared 3 years ago
423 views
Shared 3 years ago
197K views
Shared 3 years ago
306 views
Shared 3 years ago
390 views
Shared 3 years ago
236 views
Shared 3 years ago
178 views
Shared 3 years ago
185 views
Shared 3 years ago
260 views
Shared 3 years ago
440 views
Shared 3 years ago
502 views
Shared 3 years ago
223 views
Shared 3 years ago
110 views
Shared 3 years ago
568 views
Shared 3 years ago
488 views
Shared 3 years ago
504 views
Shared 3 years ago
538 views
Shared 3 years ago
316 views
Shared 3 years ago
372 views
Shared 3 years ago
161 views
Shared 3 years ago
610 views
Shared 3 years ago
243 views
Shared 3 years ago
549 views
Shared 3 years ago
113 views
Shared 3 years ago
106 views
Shared 3 years ago
89 views
Shared 3 years ago
71 views
Shared 3 years ago
103 views